Prevalence of anti-GAD antibodies as biomarkers of latent autoimmune diabetes in adults (LADA), in patients diagnosed with type 2 diabetes
DOI:
https://doi.org/10.5377/universitas.v16i1.19057Keywords:
anti-GAD, glycosylated hemoglobin, LADA, C-peptide.Abstract
Diabetes mellitus (DM) is a chronic-degenerative disease. Type 1 diabetes, characterized by autoimmune destruction of insulin-producing β cells, and type 2 diabetes caused by resistance to the actions of insulin are routinely described. However, LADA diabetes shares immunological and clinical characteristics with both types of diabetes and it is estimated that 2-12% of adults diagnosed with T2DM could be suffering from LADA, leading to early complications due to a wrong diagnosis.In this study, the prevalence of anti-GAD antibodies as biomarkers of LADA and its relationship with the biochemical-clinical profile of 80 patients diagnosed with T2DM were estimated with the aim of characterizing them immunologically and biochemically. Biochemical-clinical parameters such as body mass index (BMI), glycosylated hemoglobin (HbA1c) and C-peptide were determined and compared according to the presence of antibodies. The female sex (65%) and the 50-59 year old group (38.8%) predominated; with an average HbA1c and C−peptide of 9.88% and 1.69 ng/mL respectively were found. The prevalence of anti-GAD was 5%, predominating in men (75%) and in the 30-39 year old group (75%). Patients positive for anti-GAD debuted early with DM (36.5 vs 47.9 years) (p=0.021), had lower BMI (23.8 vs 29.2) (p=0.006) and C-peptide (0.26 vs 1.38) (p=0.002) and higher HbA1c (13.65 vs 9.15) (p=0.002). The prevalence of anti-GAD antibodies was 5%. The biochemical-clinical profile of positive patients was characterized by an increase in HbA1c, lower C-peptide and BMI.
Downloads
References
Acción LADA Recuperado 16 de febrero de 2024, de https:
//actionlada.org/method/method.html
Al-Zubairi, T., AL-Habori, M., & Saif-Ali, R. (2021). Latent
Autoimmune Diabetes in Adults (LADA) and its Metabolic Characte
ristics among Yemeni Type 2 Diabetes Mellitus Patients. Diabetes,
Metabolic Syndrome and Obesity: Targets and Therapy, 14, 4223-
https://doi.org/10.2147/DMSO.S332416
American Diabetes Association. (2011). Diagnosis and Classification
of Diabetes Mellitus. Diabetes Care, 35(Supplement_1), S64-S71.
https://doi.org/10.2337/dc12-s064
Arranz Martín, A., Lecumberri Pascual, E., Brito Sanfiel, M. Á.,
Andía Melero, V., Nattero Chavez, L., Sánchez López, I., Cánovas
Molina, G., Arrieta Blanco, F., & González Pérez del Villar, N. (2017).
Perfil clínico y metabólico de pacientes con diabetes tipo LADA
atendidos en atención especializada en la comunidad de Madrid.
Endocrinología, Diabetes y Nutrición, 64(1), 34-39. https://doi.
org/10.1016/j.endinu.2016.09.001
Groop, L. C., Bottazzo, G. F., & Doniach, D. (1986). Islet cell
antibodies identify latent type I diabetes in patients aged 35-75
years at diagnosis. Diabetes, 35(2), 237-241. https://doi.org/10.2337/
diab.35.2.237
Hebert Teobaldo Ramos Choque. (2012). Detección de
Diabetes Autoinmune Latente del Adulto (LADA) en Pacientes con
Diagnóstico de Diabetes Mellitus Tipo 2 en el «Centro de Salud Pedro
P. Díaz» en el año 2012 [Universidad Católica de Santa María]. https://
repositorio.ucsm.edu.pe/server/api/core/bitstreams/0fe854d7-
ae47-4033-b943-6318979d404e/content
Huici Moreno, M. J., Herrera del Rey, M. T., Álvarez Ríos, A. I.,
Domínguez Pascual, I., Infante Fontán, R., León-Justel, A., & Guerrero
Montávez, J. M. (2011). Estudio de autoanticuerpos en el
inicio de la diabetes autoinmune en nuestro medio mediante ELISA.
Revista del Laboratorio Clínico, 4(2), 77-83. https://doi.org/10.1016/j.
labcli.2011.01.005
Lerman, I., Granados, J., Aguilar-Salinas, C., Lobato, M.,
Villa, A. R., Velasco, M. L., & Gómez-Pérez, F. J. (2010). Baja prevalencia
de autoinmunidad (anticuerpos anti GAD +) en pacientes adultos con
diabetes tipo 2 de inicio temprano. Revista de Endocrinología y
Nutrición, 18(4), 170-175.
Maioli, M., Pes, G. M., Delitala, G., Puddu, L., Falorni, A., Tolu, F.,
Lampis, R., Orrù, V., Secchi, G., Cicalò, A. M., Floris, R., Madau, G. F.,
Pilosu, R. M., Whalen, M., & Cucca, F. (2010). Number of autoantibodies
and HLA genotype, more than high titers of glutamic acid
decarboxylase autoantibodies, predict insulin dependence in latent
autoimmune diabetes of adults. European Journal of Endocrinology,
(4), 541-549. https://doi.org/10.1530/EJE-10-0427
Manisha, A. M., Shangali, A. R., Mfinanga, S. G., & Mbugi, E. V.
(2022). Prevalence and factors associated with latent autoimmune
diabetes in adults (LADA): A cross-sectional study. BMC Endocrine
Disorders, 22(1), 175. https://doi.org/10.1186/s12902-022-01089-1
Ministerio de salud [MINSA] (2023). (2023). Mapa Nacional de La Salud
En Nicaragua. https://mapasalud.minsa.gob.ni/mapa-depadecimientos-
de-salud-de-nicaragua/
Muazu, S. B., Okpe, I., & Anumah, F. (2016). The prevalence
and characteristics of latent autoimmune diabetes in adults subset
among type two diabetes mellitus patients in Northern Nigeria.
Annals of African Medicine, 15(4), 163-170. https://doi.
org/10.4103/1596-3519.194277
Naik, R. G., Brooks-Worrell, B. M., & Palmer, J. P. (2009). Latent
Autoimmune Diabetes in Adults. The Journal of Clinical Endocrinology
& Metabolism, 94(12), 4635-4644. https://doi.org/10.1210/jc.2009-
Nolasco-Rosales, G. A., Ramírez-González, D., Rodríguez-Sánchez, E.,
Ávila-Fernandez, Á., Villar-Juarez, G. E., González-Castro, T. B.,
Tovilla-Zárate, C. A., Guzmán-Priego, C. G., Genis-Mendoza, A. D., Ble-
Castillo, J. L., Marín-Medina, A., & Juárez-Rojop, I. E. (2023).
Identification and phenotypic characterization of patients with LADA
in a population of southeast Mexico. Scientific Reports, 13, 7029.
https://doi.org/10.1038/s41598-023-34171-2
Organización Panamericana de la Salud/Organización Mundial de la
Salud [OPS/OMS]. Diabetes. (2022). Recuperado 29 de marzo de
, de https://www.paho.org/es/temas/diabetes
Organización Panamericana de la Salud/Organización Mundial de
la Salud [OPS/OMS]. Obesidad y sobrepeso. Recuperado 15 de mayo
de 2022, de https://www.who.int/es/news-room/fact-sheets/detail/
obesity-and-overweight
Park, Y., Hong, S., Park, L., Woo, J., Baik, S., Nam, M., Lee, K., Kim,
Y., & KNDP collaboratory Group. (2011). LADA prevalence estimation
and insulin dependency during follow-up. Diabetes/Metabolism
Research and Reviews, 27(8), 975-979. https://doi.org/10.1002/
dmrr.1278
Pieralice, S., & Pozzilli, P. (2018). Latent Autoimmune Diabetes in Adults:
A Review on Clinical Implications and Management. Diabetes & Me
tabolism Journal, 42(6), 451-464. https://doi.org/10.4093/
dmj.2018.0190
Rubio Cabezas, Ó., & Argente, J. (2012). Diabetes mellitus: Formas
de presentación clínica y diagnóstico diferencial de la hiperglucemia
en la infancia y adolescencia. Anales de Pediatría, 77(5), 344.e1-344.
e16. https://doi.org/10.1016/j.anpedi.2012.06.013
Tam, A. A., Ozdemir, D., Bestepe, N., Dellal, F. D., Bilginer, M. C.,
Faki, S., Bicer, C., Ersoy, R., & Cakir, B. (2020). Low rate of latent
autoimmune diabetes in adults (LADA) in patients followed for type
diabetes: A single center’s experience in Turkey. Archives of Endo
crinology and Metabolism, 64, 584-590. https://doi.
org/10.20945/2359-3997000000268
Taverna, D. M., Frechtel, G., Poskus, E., Perone, M., Matejic, A., Trifone,
L., Gonzalez, J., Amorin, M. A. A., & Domínguez, J. M. (2012). Diabe
tes autoinmune latente del adulto. LADA. 46.
Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A.,
Nissén, M., Ehrnström, B. O., Forsén, B., Snickars, B., Lahti, K., Fors
blom, C., Saloranta, C., Taskinen, M. R., & Groop, L. C. (1999). Clini
cal and genetic characteristics of type 2 diabetes with and without
GAD antibodies. Diabetes, 48(1), 150-157. https://doi.org/10.2337/
diabetes.48.1.150
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay,
I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997). UKPDS 25:
Autoantibodies to islet-cell cytoplasm and glutamic acid de
carboxylase for prediction of insulin requirement in type 2 diabe
tes. The Lancet, 350(9087), 1288-1293. https://doi.org/10.1016/
S0140-6736(97)03062-6
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors
contributing to type 2 diabetes and recent advances in the treat
ment and prevention. International Journal of Medical Sciences,
(11), 1185-1200. https://doi.org/10.7150/ijms.10001
Xiang, Y., Huang, G., Zhu, Y., Zuo, X., Liu, X., Feng, Q., Li, X., Yang, T.,
Lu, J., Shan, Z., Liu, J., Tian, H., Ji, Q., Zhu, D., Ge, J., Lin, L., Chen, L.,
Guo, X., Zhao, Z., … On Behalf of the China National Diabetes and
Metabolic Disorders Study Group. (2019). Identification of autoim
mune type 1 diabetes and multiple organ‐specific autoantibodies in
adult‐onset non‐insulin‐requiring diabetes in China: A populationbased
multicentre nationwide survey. Diabetes, Obesity and Meta
bolism, 21(4), 893-902. https://doi.org/10.1111/dom.13595
Zinman, B., Kahn, S. E., Haffner, S. M., O’Neill, M. C., Heise, M. A.,
Freed, M. I., & ADOPT Study Group. (2004). Phenotypic Characte
ristics of GAD Antibody-Positive Recently Diagnosed Patients With
Type 2 Diabetes in North America and Europe. Diabetes, 53(12),
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 National Autonomous University of Nicaragua, León.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright © Universitas (León), Revista Cientifíca de la UNAN-León. VIP+PS
